Skip to main content
  • Imaging
      |Imaging
    • Cardiac
    • Clinical Research
    • COVID
    • Interventional
    • Molecular
    • Neuro
    • Nuclear
    • Oncology
    • Orthopedic
    • Radiation Oncology
    • Screening
    • Women's
  • Technology
      |Technology
    • Artificial Intelligence
    • Contrast
    • CT
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • MRI
    • PACS
    • PET/CT
    • Ultrasound
    • X-Ray
  • Management
      |Management
    • Education & Training
    • Leadership
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHRA
    • ACR
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home

Matt O'Connor

Matt O'Connor



Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

LATEST ARTICLES BY THIS AUTHOR

4D flow MRI has potential role for detecting complications in patients with aortic disease
Hybrid PET/CT early after treatment guides crucial decisions for many liver cancer patients
Screening mammography ‘signals’ predict women’s breast cancer risk
Imaging consortium releases first-of-its-kind database to help fight lung disease
Radiology leaders share 5 pearls of wisdom for navigating burnout
Health system teams up with radiopharmaceutical specialist to advance PSMA imaging
New guidance for knee cartilage MRI seeks to prevent irreversible osteoarthritis
Ditching paper for e-worklist translates to ‘substantially’ shorter wait times for breast imaging patients
New $100K project will utilize brain MRIs to study COVID brain fog and dementia
Lawmakers request records from FDA on Alzheimer’s drug approval, citing ‘apparent anomalies’

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …23
    • Page 24
    • Page 25
    • Page 26
    • Current page 27
    • Page 28
    • Page 29
    • Page 30
    • Page 31 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme